Vaxart, Inc.
VXRT
$0.347
-$0.01-2.80%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 90.31% | 37.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 90.31% | 37.48% | |||
| Cost of Revenue | 61.77% | 35.71% | |||
| Gross Profit | -1.39% | -32.12% | |||
| SG&A Expenses | -9.26% | 25.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.72% | 34.24% | |||
| Operating Income | 2.22% | -29.96% | |||
| Income Before Tax | 3.42% | -31.22% | |||
| Income Tax Expenses | -78.95% | -46.02% | |||
| Earnings from Continuing Operations | 3.88% | -30.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.88% | -30.09% | |||
| EBIT | 2.22% | -29.96% | |||
| EBITDA | 2.22% | -37.08% | |||
| EPS Basic | 4.09% | -29.79% | |||
| Normalized Basic EPS | 3.53% | -31.17% | |||
| EPS Diluted | 4.09% | -29.79% | |||
| Normalized Diluted EPS | 3.53% | -31.17% | |||
| Average Basic Shares Outstanding | 0.19% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||